With an experienced team comprised of around 200 highly skilled professionals, the company is able to span the entire value chain of biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. * Identification of new portfolio candidates for our development pipeline based on a variety of criteria including commercial attractiveness in our target markets, therapeutic area, competitive environment, development requirements * Development of portfolio prioritization frameworks aligned with strategic, financial, and market‑driven objectives * Lead development of robust business cases, including valuation, scenario modeling, sensitivity analyses, and risk assessments * Several years of senior experience in portfolio management, strategy, market ...
mehr